Heard S O
Department of Anesthesiology, Umass Memorial Medical Center, 55 Lake Avenue North, Worcester, MA 01655, USA.
Ann Acad Med Singap. 2001 Jul;30(4):419-29.
Catheter infection continues to be a serious problem in critically ill patients. This review will examine the incidence, epidemiology, microbiology, diagnosis, risk factors for and treatment of catheter-related bloodstream infections.
Relevant articles were culled from a Medline search and other review articles on catheter-related infection. Important abstracts presented within the past year were included in the review if the data had not been published in a peer-reviewed journal.
Catheter-related bloodstream infections (CRBSI) increase morbidity and the cost of care of patients. The predominant organisms associated with CRBSI are coagulase negative staphylococci, enterococci and Staphylococcus aureus. Diagnosis usually requires catheter removal and culture but newer techniques such as "differential time to positivity" may permit diagnosis of CRBSI in situ. Reducing risk factors for infection are important: education of house staff, use of the subclavian insertion site, skin preparation with chlorhexidine solutions, use of maximum barrier precautions during catheter insertion and catheter maintenance with chlorhexidine sponges. If infection rates are still high after institution of these measures, use of antiseptic or antibiotic-impregnated catheters should be considered. Treatment of CRBSI in critically ill patients mandates catheter removal and treatment with systemic antibiotics.
The best treatment for CRBSI is prevention. Ongoing studies are evaluating the effectiveness of newer antiseptic catheters, the risk of developing antibiotic resistance when using antibiotic-impregnated catheters and the contribution of multiple interventions on the development of CRBSI.
导管感染仍是重症患者面临的严重问题。本综述将探讨导管相关血流感染的发病率、流行病学、微生物学、诊断、危险因素及治疗。
从医学文献数据库检索及其他关于导管相关感染的综述文章中筛选相关文章。若过去一年发表的重要摘要的数据尚未在同行评审期刊上发表,则纳入本综述。
导管相关血流感染(CRBSI)增加了患者的发病率和护理成本。与CRBSI相关的主要病原体是凝固酶阴性葡萄球菌、肠球菌和金黄色葡萄球菌。诊断通常需要拔除导管并进行培养,但“阳性时间差异”等新技术可能允许原位诊断CRBSI。降低感染危险因素很重要:对住院医师进行教育,使用锁骨下插入部位,用洗必泰溶液进行皮肤准备,在导管插入和维护过程中使用最大屏障预防措施,并用洗必泰海绵进行导管维护。如果采取这些措施后感染率仍然很高,应考虑使用含抗菌剂或抗生素的导管。重症患者CRBSI的治疗要求拔除导管并用全身性抗生素治疗。
CRBSI的最佳治疗方法是预防。正在进行的研究正在评估新型抗菌导管的有效性、使用含抗生素导管时产生抗生素耐药性的风险以及多种干预措施对CRBSI发生的影响。